The short extension suggests the deal is on track but requires a few more days to close. Monitor for a closing announcement or a further extension by July 21. A failure to close by the new date would be a bearish signal.
Price Chart
Executive Summary
Lisata Therapeutics (LSTA) and Kuva Labs extended the Outside Date of their existing Merger Agreement from July 17, 2026 to July 21, 2026 via a simple amendment. This is a procedural four-day extension of the deal deadline, indicating the parties are still working to close but have not yet satisfied all conditions. The filing contains no new financial terms, no change in consideration, and no indication of deal risk beyond the need for more time.
Key Financial Metrics
Key Facts
- Lisata, Kuva Labs, and Kuva Acquisition Corp. entered into an amendment to the Merger Agreement dated March 6, 2026.
- The Outside Date was extended from July 17, 2026 to July 21, 2026.
- No changes were made to the financial terms, conditions, or structure of the merger.
- The amendment was signed on July 16, 2026, one day before the original Outside Date.
Financial Impact
No financial impact; the deal value and terms remain unchanged.
Risk Factors
- Deal fails to close by the extended July 21 Outside Date.
- Unforeseen regulatory or shareholder hurdles emerge in the final days.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-028763 |
| Document: ef20078177_exhibit2-1.htm | 0001140361-26-028763 |
| Document: 0001140361-26-028763-index-headers.html | 0001140361-26-028763 |
| Document: 0001140361-26-028763-index.html | 0001140361-26-028763 |
| Document: 0001140361-26-028763.txt | 0001140361-26-028763 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | DEF 14A | $1.00 | awaiting T+60 | — | $1.02 (−2.00%) |
Oct 14, 2026 13d ago | 8-K | $1.07 | awaiting T+60 | — | $1.02 (−4.67%) |
Sep 17, 2026 5w ago | 8-K | $1.74 | awaiting T+60 | — | $1.02 (−41.38%) |
Sep 17, 2026 5w ago | Press Release | $1.74 | awaiting T+60 | — | $1.02 (−41.38%) |
Aug 4, 2026 12w ago | 8-K | $1.14 | awaiting T+60 | — | $1.02 (+10.53%) |
Jul 24, 2026 13w ago | 8-K | $1.67 $1.00 | ▲ +40.12% | ▲ +43.41% | $1.02 (+38.92%) |
Jul 17, 2026 14w ago | 8-K | $3.60 $1.05 | ▼ −70.79% | ▼ −75.48% | $1.02 (−71.63%) |
Jun 10, 2026 19w ago | Press Release | $3.61 $1.64 | ▼ −54.57% | ▼ −61.15% | $1.02 (−71.75%) |
Jun 9, 2026 20w ago | 8-K | $3.46 $1.57 | ▲ +54.62% | ▲ +58.44% | $1.02 (+70.52%) |
Jun 1, 2026 21w ago | 8-K | $3.58 $1.74 | ▲ +51.40% | ▲ +52.63% | $1.02 (+71.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers